Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Hanna CR, O'Cathail SM, Graham JS, Saunders M, Samuel L, Harrison M, Devlin L, Edwards J, Gaya DR, Kelly CA, Lewsley LA, Maka N, Morrison P, Dinnett L, Dillon S, Gourlay J, Platt JJ, Thomson F, Adams RA, Roxburgh CSD.
Hanna CR, et al. Among authors: roxburgh csd.
Radiat Oncol. 2021 Dec 2;16(1):230. doi: 10.1186/s13014-021-01941-z.
Radiat Oncol. 2021.
PMID: 34857017
Free PMC article.
No abstract available.